Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Lario Therapeutics Logo
Lario Therapeutics Growth Score
87
CB Rank
53391
Heat Score
63
Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
Founded
obfuscation
PrivateGrant Edinburgh, Edinburgh, City of, United Kingdom1-10 www.lariotx.com
Biopharma
Precision Medicine
Therapeutics
Overview

Lario Therapeutics
Total Funding
obfuscation
Growth Score
87
Heat Score
63

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score87
7 pts
in past quarter
Heat Score 63
-27 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Lario Therapeutics

CB Rank
53391
Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
Founded
obfuscation
PrivateGrant Edinburgh, Edinburgh, City of, United Kingdom1-10 www.lariotx.com
Biopharma
Precision Medicine
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Lario Therapeutics Limited
Operating Status Active
Company Type For Profit
Founders  Daniel Gill, Henning Steinhagen
About the Company
Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
Contact Email info@lariotx.com
Predictions & Insights

Growth Insight

See this Growth Insight
Lario Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

CaV2.3 Modulators
Orally active, CNS-penetrant inhibitors targeting the CaV2.3 voltage-gated calcium channel to treat severe neurological disorders including genetic epilepsies and Parkinson’s disease.

Research & Development

Lario Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
2
obfuscation
Michael J. Fox FoundationGrant
obfuscation
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
2
obfuscation
Michael J. Fox FoundationGrant
obfuscation
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
2
obfuscation
Michael J. Fox FoundationGrant
obfuscation
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
2
obfuscation
Michael J. Fox FoundationGrant
obfuscation
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
2
obfuscation
Michael J. Fox FoundationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
2
obfuscation
Michael J. Fox FoundationGrant
obfuscation
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
2
obfuscation
Michael J. Fox FoundationGrant
obfuscation
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
2
obfuscation
Michael J. Fox FoundationGrant
obfuscation
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
2
obfuscation
Michael J. Fox FoundationGrant
obfuscation
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
2
obfuscation
Michael J. Fox FoundationGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Wellcome Trust Logo
Wellcome Trust
—
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
—
Wellcome Trust Logo
Wellcome Trust
—
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
—
Wellcome Trust Logo
Wellcome Trust
—
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
—
Wellcome Trust Logo
Wellcome Trust
—
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
—
Wellcome Trust Logo
Wellcome Trust
—
Grant - Lario Therapeutics Logo
Grant - Lario Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3

Employee Profiles

News

News and Press

News•Feb 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

415
-47.2%
 in past month

Active Website Tech Count

3Lario Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 10m, and  Lorem Ipsum.

Total IP

9The intellectual property of Lario Therapeutics includes 7 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery. Additionally, Lario Therapeutics has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Lario Therapeutics's headquarters? Lario Therapeutics is located in Edinburgh, Edinburgh, City of, United Kingdom.Who invested in Lario Therapeutics? Lario Therapeutics has 2 investors including Wellcome Trust and  Michael J. Fox Foundation.When was the last funding round for Lario Therapeutics? Lario Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are Lario Therapeutics's competitors? Alternatives and possible competitors to Lario Therapeutics may include Rapport Therapeutics, Nura Bio, and  Lundbeck.How much funding has Lario Therapeutics raised to date? Lario Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f8e1fc8 1)
|